Literature DB >> 2607692

A new method of modified radical mastectomy for breast cancer.

Y Murayama1, M Sakamoto, A Oshima, Y Mishima, K Asano.   

Abstract

We have developed a new type of modified radical mastectomy, the method and clinical results of which are reported herein. In this operation, axillary dissection is performed by the following two approaches. Firstly, the axillary contents are dissected from the highest possible subclavicular point to the pectoralis minor muscle, after partially cutting the sternocostal origin of the pectoralis major muscle. The second approach is from the posterior aspect of the pectoralis minor muscle to the lateral portion of the latissimus dorsi muscle. Parasternal dissection can also be performed for stage II and IIIa cancers with a central or medial tumor. After lymph node dissection, the detached edge of the sternocostal origin of the pectoralis major muscle is resutured to cover the parasternal region. Thus, complete dissection of the axillary nodes is performed whilst preserving the pectoralis major and pectoralis minor muscles. Good clinical results were achieved with respect to radicality, cosmetic effects and function in 28 patients with stage I, II, and IIIa breast cancers who were followed up for between 5 to 8 years. This new operation may therefore be adopted for the majority of patients with Stage I, II, or IIIa cancers, unless massive infiltration into the pectoralis major muscle has occurred. Preservation of both the pectoralis major and pectoralis minor muscles results in a good cosmetic appearance, good functioning of the arm and easy reconstruction of the breast following mastectomy.

Entities:  

Mesh:

Year:  1989        PMID: 2607692     DOI: 10.1007/bf02471719

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  11 in total

1.  Excision of the internal mammary chain in radical mastectomy; results in 57 cases.

Authors:  R S HANDLEY; D H PATEY; B H HAND
Journal:  Lancet       Date:  1956-04-21       Impact factor: 79.321

2.  I. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894.

Authors:  W S Halsted
Journal:  Ann Surg       Date:  1894-11       Impact factor: 12.969

3.  [Indication of modified radical mastectomy in breast cancer].

Authors:  Y Murayama; Y Mishima
Journal:  Nihon Gan Chiryo Gakkai Shi       Date:  1985-06-20

4.  Dose-response effect of adjuvant chemotherapy in breast cancer.

Authors:  G Bonadonna; P Valagussa
Journal:  N Engl J Med       Date:  1981-01-01       Impact factor: 91.245

5.  Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five-year results of an international cooperative study.

Authors:  J Lacour; P Bucalossi; E Cacers; G Jacobelli; T Koszarowski; M Le; C Rumeau-Rouquette; U Veronesi
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

6.  Breast conservation in the treatment of early breast cancer. A 20-year follow-up.

Authors:  M P Osborne; N Ormiston; C L Harmer; J A McKinna; J Baker; W P Greening
Journal:  Cancer       Date:  1984-01-15       Impact factor: 6.860

7.  The significance of the internal mammary lymph nodes in medially located breast cancer.

Authors:  J M Roseman; A G James
Journal:  Cancer       Date:  1982-10-01       Impact factor: 6.860

8.  Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast.

Authors:  U Veronesi; R Saccozzi; M Del Vecchio; A Banfi; C Clemente; M De Lena; G Gallus; M Greco; A Luini; E Marubini; G Muscolino; F Rilke; B Salvadori; A Zecchini; R Zucali
Journal:  N Engl J Med       Date:  1981-07-02       Impact factor: 91.245

Review 9.  Staging of breast cancer: a new rationale for internal mammary node biopsy.

Authors:  M Morrow; R S Foster
Journal:  Arch Surg       Date:  1981-06

10.  The prognosis of carcinoma of the breast in relation to the type of operation performed.

Authors:  D H PATEY; W H DYSON
Journal:  Br J Cancer       Date:  1948-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.